The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sarcopenia Treatment Supplements Market Research Report 2025
Synopsis
There is no approved treatment option available for sarcopenia treatment but nutrition and dietary supplements have a key role in sarcopenia treatment.Major Sarcopenia treatment supplement comprises of protein, amino acids, creatine, omega 3 acid, vitamin D and B12, calcium carbonate. Nutrition prevents accelerated muscle loss during a period of muscle disuse and maintains energy.
The global Sarcopenia Treatment Supplements market was valued at US$ 2762.8 million in 2023 and is anticipated to reach US$ 3768.4 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sarcopenia Treatment Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sarcopenia Treatment Supplements.
Report Scope
The Sarcopenia Treatment Supplements market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sarcopenia Treatment Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sarcopenia Treatment Supplements companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Nestlé
Pfizer
Amway
By-health
Usana
A&Z Pharmaceutical
GlaxoSmithKline
Bayer
H&H
Blackmores
Zhendong Group
Segment by Type
Protein Supplements
Calcium Supplements
Others
Segment by Application
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sarcopenia Treatment Supplements companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
There is no approved treatment option available for sarcopenia treatment but nutrition and dietary supplements have a key role in sarcopenia treatment.Major Sarcopenia treatment supplement comprises of protein, amino acids, creatine, omega 3 acid, vitamin D and B12, calcium carbonate. Nutrition prevents accelerated muscle loss during a period of muscle disuse and maintains energy.
The global Sarcopenia Treatment Supplements market was valued at US$ 2762.8 million in 2023 and is anticipated to reach US$ 3768.4 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sarcopenia Treatment Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sarcopenia Treatment Supplements.
Report Scope
The Sarcopenia Treatment Supplements market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sarcopenia Treatment Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sarcopenia Treatment Supplements companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Nestlé
Pfizer
Amway
By-health
Usana
A&Z Pharmaceutical
GlaxoSmithKline
Bayer
H&H
Blackmores
Zhendong Group
Segment by Type
Protein Supplements
Calcium Supplements
Others
Segment by Application
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sarcopenia Treatment Supplements companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sarcopenia Treatment Supplements Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Protein Supplements
1.2.3 Calcium Supplements
1.2.4 Others
1.3 Market by Application
1.3.1 Global Sarcopenia Treatment Supplements Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sarcopenia Treatment Supplements Market Perspective (2019-2030)
2.2 Sarcopenia Treatment Supplements Growth Trends by Region
2.2.1 Global Sarcopenia Treatment Supplements Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sarcopenia Treatment Supplements Historic Market Size by Region (2019-2024)
2.2.3 Sarcopenia Treatment Supplements Forecasted Market Size by Region (2025-2030)
2.3 Sarcopenia Treatment Supplements Market Dynamics
2.3.1 Sarcopenia Treatment Supplements Industry Trends
2.3.2 Sarcopenia Treatment Supplements Market Drivers
2.3.3 Sarcopenia Treatment Supplements Market Challenges
2.3.4 Sarcopenia Treatment Supplements Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sarcopenia Treatment Supplements Players by Revenue
3.1.1 Global Top Sarcopenia Treatment Supplements Players by Revenue (2019-2024)
3.1.2 Global Sarcopenia Treatment Supplements Revenue Market Share by Players (2019-2024)
3.2 Global Sarcopenia Treatment Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sarcopenia Treatment Supplements Revenue
3.4 Global Sarcopenia Treatment Supplements Market Concentration Ratio
3.4.1 Global Sarcopenia Treatment Supplements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sarcopenia Treatment Supplements Revenue in 2023
3.5 Sarcopenia Treatment Supplements Key Players Head office and Area Served
3.6 Key Players Sarcopenia Treatment Supplements Product Solution and Service
3.7 Date of Enter into Sarcopenia Treatment Supplements Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sarcopenia Treatment Supplements Breakdown Data by Type
4.1 Global Sarcopenia Treatment Supplements Historic Market Size by Type (2019-2024)
4.2 Global Sarcopenia Treatment Supplements Forecasted Market Size by Type (2025-2030)
5 Sarcopenia Treatment Supplements Breakdown Data by Application
5.1 Global Sarcopenia Treatment Supplements Historic Market Size by Application (2019-2024)
5.2 Global Sarcopenia Treatment Supplements Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sarcopenia Treatment Supplements Market Size (2019-2030)
6.2 North America Sarcopenia Treatment Supplements Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sarcopenia Treatment Supplements Market Size by Country (2019-2024)
6.4 North America Sarcopenia Treatment Supplements Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sarcopenia Treatment Supplements Market Size (2019-2030)
7.2 Europe Sarcopenia Treatment Supplements Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sarcopenia Treatment Supplements Market Size by Country (2019-2024)
7.4 Europe Sarcopenia Treatment Supplements Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sarcopenia Treatment Supplements Market Size (2019-2030)
8.2 Asia-Pacific Sarcopenia Treatment Supplements Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sarcopenia Treatment Supplements Market Size by Region (2019-2024)
8.4 Asia-Pacific Sarcopenia Treatment Supplements Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sarcopenia Treatment Supplements Market Size (2019-2030)
9.2 Latin America Sarcopenia Treatment Supplements Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sarcopenia Treatment Supplements Market Size by Country (2019-2024)
9.4 Latin America Sarcopenia Treatment Supplements Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sarcopenia Treatment Supplements Market Size (2019-2030)
10.2 Middle East & Africa Sarcopenia Treatment Supplements Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sarcopenia Treatment Supplements Market Size by Country (2019-2024)
10.4 Middle East & Africa Sarcopenia Treatment Supplements Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Sarcopenia Treatment Supplements Introduction
11.1.4 Abbott Laboratories Revenue in Sarcopenia Treatment Supplements Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Nestlé
11.2.1 Nestlé Company Detail
11.2.2 Nestlé Business Overview
11.2.3 Nestlé Sarcopenia Treatment Supplements Introduction
11.2.4 Nestlé Revenue in Sarcopenia Treatment Supplements Business (2019-2024)
11.2.5 Nestlé Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Sarcopenia Treatment Supplements Introduction
11.3.4 Pfizer Revenue in Sarcopenia Treatment Supplements Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Amway
11.4.1 Amway Company Detail
11.4.2 Amway Business Overview
11.4.3 Amway Sarcopenia Treatment Supplements Introduction
11.4.4 Amway Revenue in Sarcopenia Treatment Supplements Business (2019-2024)
11.4.5 Amway Recent Development
11.5 By-health
11.5.1 By-health Company Detail
11.5.2 By-health Business Overview
11.5.3 By-health Sarcopenia Treatment Supplements Introduction
11.5.4 By-health Revenue in Sarcopenia Treatment Supplements Business (2019-2024)
11.5.5 By-health Recent Development
11.6 Usana
11.6.1 Usana Company Detail
11.6.2 Usana Business Overview
11.6.3 Usana Sarcopenia Treatment Supplements Introduction
11.6.4 Usana Revenue in Sarcopenia Treatment Supplements Business (2019-2024)
11.6.5 Usana Recent Development
11.7 A&Z Pharmaceutical
11.7.1 A&Z Pharmaceutical Company Detail
11.7.2 A&Z Pharmaceutical Business Overview
11.7.3 A&Z Pharmaceutical Sarcopenia Treatment Supplements Introduction
11.7.4 A&Z Pharmaceutical Revenue in Sarcopenia Treatment Supplements Business (2019-2024)
11.7.5 A&Z Pharmaceutical Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Sarcopenia Treatment Supplements Introduction
11.8.4 GlaxoSmithKline Revenue in Sarcopenia Treatment Supplements Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Sarcopenia Treatment Supplements Introduction
11.9.4 Bayer Revenue in Sarcopenia Treatment Supplements Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 H&H
11.10.1 H&H Company Detail
11.10.2 H&H Business Overview
11.10.3 H&H Sarcopenia Treatment Supplements Introduction
11.10.4 H&H Revenue in Sarcopenia Treatment Supplements Business (2019-2024)
11.10.5 H&H Recent Development
11.11 Blackmores
11.11.1 Blackmores Company Detail
11.11.2 Blackmores Business Overview
11.11.3 Blackmores Sarcopenia Treatment Supplements Introduction
11.11.4 Blackmores Revenue in Sarcopenia Treatment Supplements Business (2019-2024)
11.11.5 Blackmores Recent Development
11.12 Zhendong Group
11.12.1 Zhendong Group Company Detail
11.12.2 Zhendong Group Business Overview
11.12.3 Zhendong Group Sarcopenia Treatment Supplements Introduction
11.12.4 Zhendong Group Revenue in Sarcopenia Treatment Supplements Business (2019-2024)
11.12.5 Zhendong Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Sarcopenia Treatment Supplements Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Protein Supplements
Table 3. Key Players of Calcium Supplements
Table 4. Key Players of Others
Table 5. Global Sarcopenia Treatment Supplements Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Sarcopenia Treatment Supplements Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Sarcopenia Treatment Supplements Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Sarcopenia Treatment Supplements Market Share by Region (2019-2024)
Table 9. Global Sarcopenia Treatment Supplements Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Sarcopenia Treatment Supplements Market Share by Region (2025-2030)
Table 11. Sarcopenia Treatment Supplements Market Trends
Table 12. Sarcopenia Treatment Supplements Market Drivers
Table 13. Sarcopenia Treatment Supplements Market Challenges
Table 14. Sarcopenia Treatment Supplements Market Restraints
Table 15. Global Sarcopenia Treatment Supplements Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Sarcopenia Treatment Supplements Market Share by Players (2019-2024)
Table 17. Global Top Sarcopenia Treatment Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Treatment Supplements as of 2023)
Table 18. Ranking of Global Top Sarcopenia Treatment Supplements Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Sarcopenia Treatment Supplements Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sarcopenia Treatment Supplements Product Solution and Service
Table 22. Date of Enter into Sarcopenia Treatment Supplements Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sarcopenia Treatment Supplements Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Sarcopenia Treatment Supplements Revenue Market Share by Type (2019-2024)
Table 26. Global Sarcopenia Treatment Supplements Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Sarcopenia Treatment Supplements Revenue Market Share by Type (2025-2030)
Table 28. Global Sarcopenia Treatment Supplements Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Sarcopenia Treatment Supplements Revenue Market Share by Application (2019-2024)
Table 30. Global Sarcopenia Treatment Supplements Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Sarcopenia Treatment Supplements Revenue Market Share by Application (2025-2030)
Table 32. North America Sarcopenia Treatment Supplements Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Sarcopenia Treatment Supplements Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Sarcopenia Treatment Supplements Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Sarcopenia Treatment Supplements Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Sarcopenia Treatment Supplements Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Sarcopenia Treatment Supplements Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Sarcopenia Treatment Supplements Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Sarcopenia Treatment Supplements Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Sarcopenia Treatment Supplements Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Sarcopenia Treatment Supplements Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Sarcopenia Treatment Supplements Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Sarcopenia Treatment Supplements Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Sarcopenia Treatment Supplements Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Sarcopenia Treatment Supplements Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Sarcopenia Treatment Supplements Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Sarcopenia Treatment Supplements Product
Table 50. Abbott Laboratories Revenue in Sarcopenia Treatment Supplements Business (2019-2024) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. Nestlé Company Detail
Table 53. Nestlé Business Overview
Table 54. Nestlé Sarcopenia Treatment Supplements Product
Table 55. Nestlé Revenue in Sarcopenia Treatment Supplements Business (2019-2024) & (US$ Million)
Table 56. Nestlé Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Sarcopenia Treatment Supplements Product
Table 60. Pfizer Revenue in Sarcopenia Treatment Supplements Business (2019-2024) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Amway Company Detail
Table 63. Amway Business Overview
Table 64. Amway Sarcopenia Treatment Supplements Product
Table 65. Amway Revenue in Sarcopenia Treatment Supplements Business (2019-2024) & (US$ Million)
Table 66. Amway Recent Development
Table 67. By-health Company Detail
Table 68. By-health Business Overview
Table 69. By-health Sarcopenia Treatment Supplements Product
Table 70. By-health Revenue in Sarcopenia Treatment Supplements Business (2019-2024) & (US$ Million)
Table 71. By-health Recent Development
Table 72. Usana Company Detail
Table 73. Usana Business Overview
Table 74. Usana Sarcopenia Treatment Supplements Product
Table 75. Usana Revenue in Sarcopenia Treatment Supplements Business (2019-2024) & (US$ Million)
Table 76. Usana Recent Development
Table 77. A&Z Pharmaceutical Company Detail
Table 78. A&Z Pharmaceutical Business Overview
Table 79. A&Z Pharmaceutical Sarcopenia Treatment Supplements Product
Table 80. A&Z Pharmaceutical Revenue in Sarcopenia Treatment Supplements Business (2019-2024) & (US$ Million)
Table 81. A&Z Pharmaceutical Recent Development
Table 82. GlaxoSmithKline Company Detail
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Sarcopenia Treatment Supplements Product
Table 85. GlaxoSmithKline Revenue in Sarcopenia Treatment Supplements Business (2019-2024) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Bayer Company Detail
Table 88. Bayer Business Overview
Table 89. Bayer Sarcopenia Treatment Supplements Product
Table 90. Bayer Revenue in Sarcopenia Treatment Supplements Business (2019-2024) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. H&H Company Detail
Table 93. H&H Business Overview
Table 94. H&H Sarcopenia Treatment Supplements Product
Table 95. H&H Revenue in Sarcopenia Treatment Supplements Business (2019-2024) & (US$ Million)
Table 96. H&H Recent Development
Table 97. Blackmores Company Detail
Table 98. Blackmores Business Overview
Table 99. Blackmores Sarcopenia Treatment Supplements Product
Table 100. Blackmores Revenue in Sarcopenia Treatment Supplements Business (2019-2024) & (US$ Million)
Table 101. Blackmores Recent Development
Table 102. Zhendong Group Company Detail
Table 103. Zhendong Group Business Overview
Table 104. Zhendong Group Sarcopenia Treatment Supplements Product
Table 105. Zhendong Group Revenue in Sarcopenia Treatment Supplements Business (2019-2024) & (US$ Million)
Table 106. Zhendong Group Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sarcopenia Treatment Supplements Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Sarcopenia Treatment Supplements Market Share by Type: 2023 VS 2030
Figure 3. Protein Supplements Features
Figure 4. Calcium Supplements Features
Figure 5. Others Features
Figure 6. Global Sarcopenia Treatment Supplements Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Sarcopenia Treatment Supplements Market Share by Application: 2023 VS 2030
Figure 8. Online Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Sarcopenia Treatment Supplements Report Years Considered
Figure 11. Global Sarcopenia Treatment Supplements Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Sarcopenia Treatment Supplements Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Sarcopenia Treatment Supplements Market Share by Region: 2023 VS 2030
Figure 14. Global Sarcopenia Treatment Supplements Market Share by Players in 2023
Figure 15. Global Top Sarcopenia Treatment Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Treatment Supplements as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Sarcopenia Treatment Supplements Revenue in 2023
Figure 17. North America Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Sarcopenia Treatment Supplements Market Share by Country (2019-2030)
Figure 19. United States Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Sarcopenia Treatment Supplements Market Share by Country (2019-2030)
Figure 23. Germany Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Sarcopenia Treatment Supplements Market Share by Region (2019-2030)
Figure 31. China Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Sarcopenia Treatment Supplements Market Share by Country (2019-2030)
Figure 39. Mexico Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Sarcopenia Treatment Supplements Market Share by Country (2019-2030)
Figure 43. Turkey Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Sarcopenia Treatment Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Sarcopenia Treatment Supplements Business (2019-2024)
Figure 46. Nestlé Revenue Growth Rate in Sarcopenia Treatment Supplements Business (2019-2024)
Figure 47. Pfizer Revenue Growth Rate in Sarcopenia Treatment Supplements Business (2019-2024)
Figure 48. Amway Revenue Growth Rate in Sarcopenia Treatment Supplements Business (2019-2024)
Figure 49. By-health Revenue Growth Rate in Sarcopenia Treatment Supplements Business (2019-2024)
Figure 50. Usana Revenue Growth Rate in Sarcopenia Treatment Supplements Business (2019-2024)
Figure 51. A&Z Pharmaceutical Revenue Growth Rate in Sarcopenia Treatment Supplements Business (2019-2024)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Sarcopenia Treatment Supplements Business (2019-2024)
Figure 53. Bayer Revenue Growth Rate in Sarcopenia Treatment Supplements Business (2019-2024)
Figure 54. H&H Revenue Growth Rate in Sarcopenia Treatment Supplements Business (2019-2024)
Figure 55. Blackmores Revenue Growth Rate in Sarcopenia Treatment Supplements Business (2019-2024)
Figure 56. Zhendong Group Revenue Growth Rate in Sarcopenia Treatment Supplements Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
